The British Paediatric Allergy Immunity and Infection Group
(sub-committee of the Royal College of Paediatrics and Child Health)
- New evidence-based UK guidelines for the diagnosis and management of CMV have been updated in June 2016. It recommends how to diagnose, who to treat, when to treat, what to treat with, how long to treat and monitoring during treatment.
- CMV Action's publication CMV: What to expect summarises the recommendations in this guideline.
- The first set of evidence-based UK guidelines for the detection and treatment of congenital CMV were published in 2011.
The Royal College of Obstetricians and Gynacologists
- The Green Top Guildeline on Small-for-Gestational-Age-Fetus recommends that serological screening for CMV should be offered in severely small for gestational age fetuses
British Assocation of Audiological Physicians
- Guidelines for investigations into permanent hearing loss in children state that CMV testing should be carried out as soon as possible on suspecting the diagnosis of sensorineural hearing loss. It also states that a fast and reliable pathway should be developed locally to include the audiologists, doctors and the testing laboratory in order to facilitate a timely diagnosis of congenital CMV. As .
UK National Screening Committee
- Last external review of CMV against national screening criteria recommended that systematic antenatal and neonatal screening should not be carried out